|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7105 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 2359834 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11001632.6 |
| Date of filing the European patent application | 2007-03-15 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 783070 P | 2006-03-15 | US |
| (72) |
Bell, Leonard, US
Rother, Russell P., US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College Street, New Haven, CT 06510,
US
|
| (54) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |